Insight Molecular Diagnostics (IMDX)

• Market cap: $112M
• 1 day: -10.5%
• 5 days: -22.53%
• 1 month: -27.81%
• 3 months: -27.54%
• 6 months: 14.96%
• Year to date: -45.25%
• 1 year: 12%
• 5 years: -95.93%
• 10 years: -96.36%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.

Employees: 49